Treatment
Medication clinical trials
We’re tracking 7,451 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT04694339Recruiting
Study of minority barriers in anesthesia care
This study looks at barriers that minority people may face in anesthesia. It may help the team understand what changes could improve training and/or care for minority clinicians and learners.
Boston, MassachusettsAges 25–75 - NCT04695106RecruitingPhase 4
Blood Thinner and Heart Attack Prevention Study
This study tests whether taking dabigatran (a blood thinner) combined with ticagrelor (a blood clot preventer) is safe and effective for patients with irregular heart rhythm (atrial fibrillation) who recently had a heart attack and received a stent. The goal is to prevent future blood clots while minimizing bleeding risks.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT04699279Recruiting
Statin after aortic surgery to protect heart and organs
This trial tests whether taking a cholesterol-lowering medicine (a statin) after certain aortic surgeries can reduce harmful changes in the heart and other organs. You might benefit by lowering the risk of ongoing damage after your acute aortic condition and surgery.
Guangzhou, GuangdongAges 18–85 - NCT04699305Recruiting
Test of ActiGraft for draining skin wounds
This trial studies whether ActiGraft helps heal draining (exuding) skin wounds safely and effectively. If you join, the researchers may use your wound photos and health data to analyze results and publish findings.
Las Vegas, NevadaAges 18 years+ - NCT04701684Recruiting
Fast-stroke treatment workflow study to save minutes to clot removal
This study tests whether a streamlined hospital workflow can reduce the time it takes to reopen blocked blood vessels during very fast stroke treatment. Faster treatment may help more brain tissue be saved by getting endovascular (clot-removal) therapy started sooner.
Jacksonville, FloridaAges 18 years+ - NCT04702321Recruiting
Study genetic risks for childhood cancer complications in Switzerland
This study looks at genetic factors to understand why some children who had cancer develop later complications. It uses stored samples and information from a Swiss biobank to help researchers identify higher-risk children.
GenevaAges Up to 21 years - NCT04707781Recruiting
Database study for people at risk of lung scarring
This trial is a study database that collects information from adults who have other illnesses that can increase the risk of developing interstitial lung disease (lung scarring). It may help researchers better understand who is at risk and how outcomes change over time.
GrazAges 18 years+ - NCT04708171Recruiting
Compare awake, asleep, or no mapping during brain tumor surgery
This study looks at whether surgeons get better safety and control during glioblastoma removal by using awake testing, asleep testing, or no mapping. Mapping helps identify brain areas involved in movement, speech, or vision to lower the risk of serious side effects.
San Francisco, CaliforniaAges 18–90 - NCT04713657RecruitingPhase 1
Beta-blocker study for heart muscle function in young babies
This trial tests whether a beta-blocker called propranolol can improve how well heart muscle cells work in very young babies with certain congenital heart conditions. It mainly looks at safety and how the medicine affects the heart, which could help guide future treatments.
New York, New YorkAges 4 weeks–2 months - NCT04715685Recruiting
Mind-body balance program for children with migraine
This trial studies a mind-body balance approach to help reduce symptoms and disability from pediatric migraine. You may join if your child has migraine headaches and can follow study routines, including keeping a headache diary.
Aurora, ColoradoAges 10–17 - NCT04715984Recruiting
Testing brain-circuit targets during DBS surgery in Parkinson’s
This study looks at how brain connections involved in movement may relate to thinking and memory problems in Parkinson’s disease. It happens during a deep brain stimulation (DBS) operation, using tests while the surgeon is placing an electrode.
Nashville, TennesseeAges 40 years+ - NCT04721041Recruiting
Fecal microbiota transplant for gut side effects after cancer treatment
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
Nanjing, JiangsuAges 18 years+ - NCT04722341Recruiting
Time-limited eating for people with certain breast or rectal cancers
This study tests whether eating only within a shorter daily time window can improve cancer outcomes in people with specific breast or rectal cancers. It also looks at how this affects the body (such as metabolism) and who is most likely to benefit.
Birmingham, AlabamaAges 18 years+ - NCT04723095Recruiting
Cervical neuroendocrine cancer registry for past and present patients
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
Houston, TexasAges Any age - NCT04725409Recruiting
Study brain signals during psychiatric evaluations with SEEG
This study looks at brain activity to better understand psychiatric disorders. You may be able to join if you are already having a specific brain-monitoring procedure at Vanderbilt and can complete questionnaires.
Nashville, TennesseeAges 18 years+ - NCT04729543RecruitingPhase 1/Phase 2
TCR cell therapy for melanoma and head and neck cancer
This early-phase study tests a lab-made T-cell treatment that targets a specific tumor marker (MC2) in melanoma and head and neck cancers. It aims to see if the treatment can safely shrink tumors and control cancer after standard options have run out.
RotterdamAges 18 years+ - NCT04734730RecruitingPhase 2
Talazoparib plus hormone therapy for metastatic prostate cancer
This trial tests whether talazoparib added to standard hormone therapy (ADT), along with abiraterone, can better control metastatic prostate cancer that hasn’t progressed despite starting hormone treatment. It may help people live longer and delay cancer worsening.
Duarte, CaliforniaAges 18 years+ - NCT04736732Recruiting
Post-COVID research clinic for adults in Quebec
This study invites adults in Quebec to complete questionnaires and possibly follow-up checks about past COVID-19 infection or symptoms. It may help researchers better understand ongoing effects after COVID, or compare people with different COVID test histories.
Montreal, QuebecAges 18–100 - NCT04741906Recruiting
Dental implants in people taking antiresorptive medications
This study looks at how well dental implant treatment works in people with cancer or osteoporosis who take antiresorptive medicines. It may help your team understand what to expect for healing and outcomes in your situation.
Copenhagen, DanmarkAges Any age - NCT04745195Recruiting
Study of complement activity in microangiopathy affecting kidneys
This study looks at signs of a clotting problem in tiny blood vessels (called TMA) that can affect kidney function. The goal is to better understand the role of the body’s complement system and how it relates to different causes of this illness.
Maastricht, LimburgAges 18 years+ - NCT04745143RecruitingPhase 2
NMDA-enhancer medicine tested for schizophrenia without antipsychotics
This Phase 2 trial tests a single medicine intended to help people with schizophrenia who cannot take standard antipsychotic medications due to side effects or poor response. It may help reduce schizophrenia symptoms, but whether you can join depends on your diagnosis, medication history, and health conditions.
TaichungAges 18–65 - NCT04745728RecruitingPhase 3
Testing different immune-suppressing treatments for membranous kidney disease
This Phase 3 trial compares different immune-suppressing medicines for idiopathic membranous nephropathy (a kidney disease caused by the immune system). It may help reduce heavy protein leakage in the urine and improve disease control in people who fit specific prior-treatment and lab requirements.
Beijing, Beijing MunicipalityAges 18–80 - NCT04746209RecruitingPhase 2
Blinatumomab after transplant for high-risk B-ALL patients
This trial tests blinatumomab, an immune therapy, in young people with B-cell acute lymphoblastic leukemia (B-ALL) after their transplant or when they are getting ready for transplant. The goal is to lower the chance of the leukemia coming back by targeting remaining leukemia cells.
Milwaukee, WisconsinAges Up to 25 years - NCT04746677Recruiting
Stent repair for complex aortic problems when standard options fail
This trial tests whether a specially built stent-graft made for your anatomy can be done safely and effectively for complex aortic disease. It may help people who are too risky for open surgery or who cannot wait for a standard custom device to be made.
Boston, MassachusettsAges 21 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,451 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.